Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Target Oncol. 2020 Aug;15(4):541–548. doi: 10.1007/s11523-020-00739-5

Figure 2. Communication schema.

Figure 2.

for effective immune-related adverse event (IRAE) diagnosis and management. Education around IRAEs for both the patient and care providers as well as a high degree of suspicion for IRAEs are the essential tenets to effective IRAE management. The medical oncologist is a central figure in both the recognition and evaluation of IRAEs as the common point of contact for the patient and the other care team members. Additional strategies, such as patient wallet cards and electronic medical record (EMR) flags, can be helpful for notifying non-oncology providers that the patient is receiving or has received immunotherapy and IRAEs should be considered in the differential diagnosis.